Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease
Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Weight Loss Drugs May Be a New Alternative to Knee Replacements
A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
The Truth About Weight Loss Drugs
Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or tirzepatide is right for you.
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are talking the future of AI in health care.
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Opinion
Reher: Counterfeit weight-loss drug crisis looms
Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these drugs, nearly indistinguishable from the real thing.
Knockoff weight loss drugs are having a moment. Eli Lilly isn't worried
CEO David Ricks said the sale of cheaper, off-brand versions of the company’s blockbuster weight loss drug isn’t having a “financial impact” on the pharma giant.
Eli Lilly Plummets On Rare — But 'Big' — Sales Miss For Diabetes, Weight-Loss Drugs
Eli Lilly stock crashed Wednesday after the pharma giant cut its 2024 outlook following a "big" miss for its diabetes and weight-loss drugs.
Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling
Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies ...
Science Daily8d
Diet and Weight Loss News
25, 2024 — A new study has examined a large sample ... the impact of policy in the North East of ... Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease Oct. 24, ...
Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues
Employers are rushing to Omada to get the startup's help managing patients on costly drugs like Ozempic.
News Medical on MSN4d
Expanded access to weight-loss drugs could save thousands of lives
Researchers explore the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in ...
India Today on MSN7d
Popular diabetes, weight loss drug could reduce risk of Alzheimer's disease
A new study suggests that semaglutide, used for type 2 diabetes and weight loss under brand names like Wegovy and Ozempic, ...